Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 10 May 2023 08:00 CEST |
ULTIMOVACS | Ultimovacs ASA Reports First Quarter 2023 Financial Results and Provides General Business Update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 May 2023 08:00 CEST |
ULTIMOVACS | Ultimovacs ASA: Invitation to first quarter 2023 results webcast presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Apr 2023 07:00 CEST |
ULTIMOVACS | Ultimovacs provides updated guidance on timeline for readout of INITIUM Phase II clinical trial of UV1 in malignant melanoma | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Apr 2023 16:30 CEST |
ULTIMOVACS | Ultimovacs ASA - Share Option Program | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Apr 2023 15:08 CEST |
ULTIMOVACS | Ultimovacs ASA - Annual General Meeting held on 20 April 2023 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Apr 2023 08:00 CEST |
ULTIMOVACS | Ultimovacs ASA - Disclosure of voting rights of Annual General Meeting | 20103010 Biotechnology | Total number of voting rights and capital |